Skip to main content


Latest articles

21-08-2020 | Diabetes | News | Article

Fasting glucose variability in young adulthood linked to CAC progression in middle age

A prospective study has revealed that greater fasting glucose variability during young adulthood is independently associated with increased risk for coronary artery calcification progression in middle age.

20-08-2020 | Diabetes | News | Article

Collaborative care may improve diabetes, depression management in resource-limited settings

A collaborative care intervention delivered at urban diabetes clinics improves depressive symptoms and cardiometabolic outcomes among people with comorbid diabetes and depression in India, shows the INDEPENDENT trial.

19-08-2020 | Diabetes | News | Article

‘Nearly identical’ metabolic benefits with surgery vs diet in people with type 2 diabetes

Among people with obesity and type 2 diabetes, substantial weight loss is associated with similar metabolic benefits irrespective of whether it is achieved through gastric bypass surgery or diet, suggests research published in The New England Journal of Medicine.

19-08-2020 | Diabetes | News | Article

Data reject SLGT2 inhibitor link to increased amputation risk

The risk for lower limb amputation is not significantly increased among people using SGLT2 inhibitors to treat type 2 diabetes, according to findings from two studies.

18-08-2020 | Diabetes | News | Article

African Americans have high cardiometabolic risk pre- and post-SGLT2 inhibitor initiation

Among people with type 2 diabetes, those of African American descent have a higher cardiometabolic risk factor burden than Caucasians at the time of starting treatment with a SGLT2 inhibitor and this might affect long-term treatment response, study findings suggest.

17-08-2020 | Diabetes | News | Article

Type 1, type 2 diabetes linked to elevated COVID-19 mortality risk

Both type 1 and type 2 diabetes are independently associated with an increased risk for death among hospitalized patients with COVID-19, and a number of factors including poor glycemic control and BMI may predict mortality risk, suggest findings from two studies published in The Lancet Diabetes & Endocrinology.

17-08-2020 | Diabetes | News | Article

T-cell analysis may predict immunotherapy response in type 1 diabetes

Analysis of pretreatment follicular helper T cell subpopulations could help to identify which patients with newly diagnosed type 1 diabetes are likely to respond to abatacept immunotherapy, suggests research published in Nature Immunology.

14-08-2020 | Diabetes | News | Article

Dapagliflozin not linked to adverse limb events in DECLARE-TIMI 58

Dapagliflozin reduces the risk for cardiovascular events in people with type 2 diabetes, including those with peripheral artery disease, without increasing the risk for adverse limb events, show DECLARE-TIMI 58 data.

13-08-2020 | Diabetes | News | Article

Novel probiotic formulation may assist glucose control in type 2 diabetes

A pilot study indicates that a probiotic supplementation containing mostly anaerobic bacteria may have a role in controlling glucose levels in people with type 2 diabetes.

11-08-2020 | Diabetes | News | Article

​​​​​​​RA linked to reduced type 2 diabetes risk

Patients with rheumatoid arthritis have a lower risk for developing type 2 diabetes relative to individuals without the disease and those with hypertension, osteoarthritis, or psoriatic arthritis, US researchers report.

11-08-2020 | Diabetes | News | Article

Ethnic-specific diabetes screening BMI cutoffs proposed

Researchers studying the MESA cohort have proposed BMI cutoffs at which people from ethnic minorities should be screened for type 2 diabetes, all of which are lower than their proposed cutoff for White people.

10-08-2020 | Diabetes | News | Article

Youths’ diligence with insulin increases as clinic appointments draw near

Children and adolescents with type 1 diabetes become more diligent about bolusing for insulin at mealtimes in the run-up to a clinic appointment, as reflected in objective data from their insulin pumps.

07-08-2020 | Diabetes | News | Article

Case of canagliflozin-triggered rosuvastatin-induced myotoxicity reported

Canadian clinicians have reported the case of a woman on long-term rosuvastatin treatment who developed rhabdomyolysis within days of starting on canagliflozin.

06-08-2020 | Diabetes | News | Article

Socioeconomic status may flag glycemic control deterioration risk in COVID-19 lockdown

Analysis of flash glucose monitoring users in Scotland reveals that people with low socioeconomic status had an increased risk for deteriorating glycemic control during the COVID-19 lockdown.

04-08-2020 | Diabetes | News | Article

Factory-calibrated CGM may assist glucose control for young adults with type 1 diabetes

The Dexcom G6 continuous glucose monitoring system may be a good option to help young adults with type 1 diabetes control their blood glucose, show the results of the MILLENNIAL trial.

03-08-2020 | Diabetes | News | Article

Severe hypoglycemia ‘marker rather than cause’ for longer-term type 2 diabetes mortality risk

Severe hypoglycemia in people with type 2 diabetes is associated with later mortality from a wide range of causes, including those for which there is no obvious underlying mechanism, say researchers.

31-07-2020 | Diabetes | News | Article

DKA risk increased with SGLT2 inhibitor use, but low overall

A large population-based study supports an increased risk for diabetic ketoacidosis for users of SGLT2 inhibitors compared with DPP-4 inhibitors, although the absolute risk remains low.

30-07-2020 | Diabetes | News | Article

More evidence linking sleep duration with mortality risk in type 2 diabetes

Getting too little or too much sleep is associated with higher death rates among adults with type 2 diabetes when compared to individuals without diabetes, according to data from a large prospective cohort study.

28-07-2020 | Diabetes | News | Article

Youth involvement in CGM decisions may help maximize use

Involving older children with type 1 diabetes in the decision-making process about starting continuous glucose monitoring may help to ensure that they persist with the technology, report researchers.

27-07-2020 | Diabetes | News | Article

Dual targets difficult to reach in type 1 diabetes

People with type 1 diabetes treated with multiple daily insulin injections struggle to achieve guideline-recommended targets for time in hypoglycemia while simultaneously reaching their glycated hemoglobin goals, researchers report.